• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER TALISMAN PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER TALISMAN PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Catalog Number 9-PFO-2518
Device Problem Air/Gas in Device (4062)
Patient Problems Air Embolism (1697); Non specific EKG/ECG Changes (1817)
Event Date 01/16/2024
Event Type  Injury  
Event Description
It was reported that on (b)(6) 2024, an amplatzer talisman pfo occluder was chosen for implant using a 9f amplatzer torqvue delivery system.The patient was under conscious sedation.It was reported that the device was prepared per instructions for use (ifu) by the physician.During device preparation, there was no visible air on the loaded occluder prior to insertion into the patient.Once the dilator and wire were removed from the patient, the loader of the talisman pfo occluder was immediately attached to the delivery system using wet-to-wet connection.The wire and dilator were not removed too quickly or too slowly.The occluder was advanced without noting air in the system.After the left atrial and right atrial discs were placed, the physician stopped when st elevation was observed on electrocardiogram (ecg) for approximately two minutes.The st elevation was an indication of an air embolism.The st elevation subsided without intervention.No aspiration was being performed.The talisman pfo was successfully implanted.The patient status was stable and discharged.
 
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that on (b)(6) 2024, an amplatzer talisman pfo occluder was chosen for implant using a 9f amplatzer torqvue delivery system.The patient was under conscious sedation.It was reported that the device was prepared per instructions for use (ifu) by the physician.During device preparation, there was no visible air on the loaded occluder prior to insertion into the patient.Once the dilator and wire were removed from the patient, the loader of the talisman pfo occluder was immediately attached to the delivery system using wet-to-wet connection.The wire and dilator were not removed too quickly or too slowly.The occluder was advanced and air was seen while advancing the occluder.After the left atrial and right atrial discs were placed, the physician stopped when st elevation was observed on electrocardiogram (ecg) for approximately two minutes.The st elevation was an indication of an air embolism.The st elevation subsided without intervention.No aspiration was being performed.The talisman pfo was successfully implanted.The patient status was stable and discharged.
 
Manufacturer Narrative
An event of air while loading the occluder into the delivery sheath was reported.A returned device inspection, to rule out any device-related causes, could not be performed as the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed, and the product met all specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.Information from field indicated that no air entered the patient anatomy, and that the device was implanted successfully.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER TALISMAN PFO OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL REG# 2135147
5050 nathan ln n
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key18654970
MDR Text Key334722386
Report Number2135147-2024-00543
Device Sequence Number1
Product Code MLV
UDI-Device Identifier05415067033314
UDI-Public(01)05415067033314(17)260630(10)9158364
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P120021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/29/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/06/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number9-PFO-2518
Device Lot Number9158364
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/16/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured07/25/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
AMPLATZER TORQVUE DS, 9-ITV09F45/80, LOT 9020608.
Patient Outcome(s) Other;
Patient Age33 YR
Patient SexFemale
-
-